|
Japanese encephalitis virus vaccine (sa14-14-2)
|
Viral vaccines
|
13-Aug-2023 |
|
Japanese encephalitis vaccine (monograph)
|
Drugs
|
13-Aug-2023 |
|
Janssen - johnson & johnson covid-19 vaccine
|
Viral vaccines
|
13-Aug-2023 |
|
Jackass bitters
|
Drugs
|
13-Aug-2023 |
|
Ixekizumab
|
Interleukin inhibitors
|
13-Aug-2023 |
|
Ixazomib citrate (monograph)
|
Drugs
|
13-Aug-2023 |
|
Ixazomib
|
Proteasome inhibitors
|
13-Aug-2023 |
|
Ixabepilone
|
Mitotic inhibitors
|
13-Aug-2023 |
|
Ivosidenib
|
Miscellaneous antineoplastics
|
13-Aug-2023 |
|
Ivermectin (topical) (monograph)
|
Drugs
|
13-Aug-2023 |
|
Ivermectin (systemic) (monograph)
|
Drugs
|
13-Aug-2023 |
|
Ivacaftor and tezacaftor
|
CFTR combinations
|
13-Aug-2023 |
|
Ioversol
|
Non-ionic iodinated contrast media
|
13-Aug-2023 |
|
Ioflupane i-123
|
Diagnostic radiopharmaceuticals
|
13-Aug-2023 |
|
Iodoquinol (topical) (monograph)
|
Drugs
|
13-Aug-2023 |
|
Iodixanol
|
Non-ionic iodinated contrast media
|
13-Aug-2023 |
|
Imipenem, cilastatin, and relebactam
|
Carbapenems / beta-lactamase inhibitors
|
13-Aug-2023 |
|
Imipenem, cilastatin sodium, and relebactam (monograph)
|
Drugs
|
13-Aug-2023 |
|
Iloprost inhalation
|
Agents for pulmonary hypertension
|
13-Aug-2023 |
|
Idursulfase
|
Lysosomal enzymes
|
13-Aug-2023 |
|
Idelalisib
|
PI3K inhibitors
|
13-Aug-2023 |
|
Idecabtagene vicleucel
|
Miscellaneous antineoplastics
|
13-Aug-2023 |
|
Icyhot pro pain relief
|
Topical rubefacient
|
13-Aug-2023 |
|
Icyhot pro no mess
|
Topical rubefacient
|
13-Aug-2023 |
|
Icyhot pro dry
|
Topical rubefacient
|
13-Aug-2023 |
|
Icyhot advanced
|
Topical rubefacient
|
13-Aug-2023 |
|
Ibutilide
|
Group III antiarrhythmics
|
13-Aug-2023 |
|
Ibuprofen injection
|
Nonsteroidal anti-inflammatory drugs
|
13-Aug-2023 |
|
Ibuprofen and pseudoephedrine
|
Upper respiratory combinations
|
13-Aug-2023 |
|
Ibuprofen and phenylephrine
|
Upper respiratory combinations
|
13-Aug-2023 |
|
Ibritumomab
|
CD20 monoclonal antibodies
|
13-Aug-2023 |
|
Ibrexafungerp
|
Miscellaneous antifungals
|
13-Aug-2023 |
|
Hydrophor
|
Topical emollients
|
13-Aug-2023 |
|
Hydromorphone (rectal)
|
Opioids (narcotic analgesics)
|
13-Aug-2023 |
|
Hydromorphone (injection)
|
Opioids (narcotic analgesics)
|
13-Aug-2023 |
|
Hydrocortisone, neomycin, and polymyxin b otic
|
Otic steroids with anti-infectives
|
13-Aug-2023 |
|
Hydrocortisone, neomycin, and polymyxin b (ophthalmic)
|
Ophthalmic steroids with anti-infectives
|
13-Aug-2023 |
|
Hydrocortisone rectal (foam, enema)
|
Glucocorticoids
|
13-Aug-2023 |
|
Hydrocortisone rectal (cream, suppository)
|
Topical steroids
|
13-Aug-2023 |
|
Hydrocortisone (injection)
|
Glucocorticoids
|
13-Aug-2023 |
|
Hydrocortisone butyrate (eqv-locoid)
|
Topical steroids
|
13-Aug-2023 |
|
Hydrocortisone butyrate (eqv-locoid lipocream)
|
Topical steroids
|
13-Aug-2023 |
|
Hydrocortisone and pramoxine (topical/rectal)
|
Anorectal preparations
|
13-Aug-2023 |
|
Hydrocortisone and lidocaine (topical/rectal)
|
Topical anesthetics
|
13-Aug-2023 |
|
Hydrocortisone (systemic) (monograph)
|
Drugs
|
13-Aug-2023 |
|
Hydrocodone and ibuprofen
|
Narcotic analgesic combinations
|
13-Aug-2023 |
|
Hydrochlorothiazide and telmisartan
|
Angiotensin II inhibitors with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and spironolactone
|
Potassium sparing diuretics with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and quinapril
|
ACE inhibitors with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and metoprolol
|
Beta blockers with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and methyldopa
|
Antiadrenergic agents (central) with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and fosinopril
|
ACE inhibitors with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and enalapril
|
ACE inhibitors with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and captopril
|
ACE inhibitors with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and candesartan
|
Angiotensin II inhibitors with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and bisoprolol
|
Beta blockers with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and benazepril
|
ACE inhibitors with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and amiloride
|
Potassium sparing diuretics with thiazides
|
13-Aug-2023 |
|
Hydrochlorothiazide and aliskiren
|
Miscellaneous antihypertensive combinations
|
13-Aug-2023 |
|
Hydralazine and isosorbide dinitrate
|
Miscellaneous antihypertensive combinations
|
13-Aug-2023 |
|
Hyaluronidase, pertuzumab, and trastuzumab
|
HER2 inhibitors
|
13-Aug-2023 |
|
Hyaluronidase (injection)
|
Miscellaneous uncategorized agents
|
13-Aug-2023 |
|
Hyaluronidase and trastuzumab
|
HER2 inhibitors
|
13-Aug-2023 |
|
Hyaluronidase and rituximab
|
CD20 monoclonal antibodies
|
13-Aug-2023 |
|
Huperzine a
|
Drugs
|
13-Aug-2023 |
|
Human papillomavirus (hpv) vaccine, 9-valent
|
Viral vaccines
|
13-Aug-2023 |
|
House dust mite allergen extract
|
Allergenics
|
13-Aug-2023 |
|
Horsetail
|
Drugs
|
13-Aug-2023 |
|
Horse chestnut
|
Herbal products
|
13-Aug-2023 |
|
Horehound
|
Drugs
|
13-Aug-2023 |
|
Hops
|
Drugs
|
13-Aug-2023 |
|
Hoodia
|
Drugs
|
13-Aug-2023 |
|
Homatropine ophthalmic
|
Mydriatics
|
13-Aug-2023 |
|
Homatropine and hydrocodone
|
Upper respiratory combinations
|
13-Aug-2023 |
|
Histex
|
Upper respiratory combinations
|
13-Aug-2023 |
|
Hexatrione (injection)
|
Glucocorticoids
|
13-Aug-2023 |
|
Hetastarch
|
Plasma expanders
|
13-Aug-2023 |
|
Hepatitis b vaccine recombinant (monograph)
|
Drugs
|
13-Aug-2023 |
|
Hepatitis b pediatric vaccine
|
Viral vaccines
|
13-Aug-2023 |
|
Hepatitis b immune globulin
|
Immune globulins
|
13-Aug-2023 |
